Vol. 44, Issue 5, 2013January 01, 2013 CDT
ccby-4.0
Rewiring the DNA of Securities Fraud Litigation: Amgen's Missed Opportunity
Rewiring the DNA of Securities Fraud Litigation: Amgen's Missed Opportunity
Geoffrey Rapp, Rewiring the DNA of Securities Fraud Litigation: Amgen’s Missed Opportunity, 44 Loy. U. Chi. L.J. 1475 (2013).